Endothelial-Vasoprotective Effects of High-Density Lipoprotein Are Impaired in Patients With Type 2 Diabetes Mellitus but Are Improved After Extended-Release Niacin Therapy

Cited by (402)

Items 201–300 of 402

1. High-Density Lipoprotein Modifications: Causes and Functional Consequences in Type 2 Diabetes Mellitus
   Xiaodi Zhang, Emiel P. C. van der Vorst · 2024 · Cells
2. Elevated HDL-bound miR-181c-5p level is associated with diabetic vascular complications in Australian Aboriginal people
   Kaitlin R. Morrison, Emma L. Solly, Tomer Shemesh, Peter James Psaltis, Stephen James Nicholls, Alex D. H. Brown, Christina A. Bursill, Joanne T. M. Tan · 2021 · Diabetologia
3. Mechanisms of Post-critical Illness Cardiovascular Disease
   Andrew Owen, Jaimin M. Patel, Dhruv Parekh, Mansoor Nawaz Bangash · 2022 · Frontiers in Cardiovascular Medicine
4. Dysfunctional HDL: the journey from savior to slayer
   Corina Serban, Danina Mirela Muntean, Dimitri P Mikhailids, Peter Paul Toth, Maciej Banach · 2014 · Clinical Lipidology
5. Stability of serum high-density lipoprotein-microRNAs for preanalytical conditions
   Hiroaki Ishikawa, Hiroya Yamada, Nao Taromaru, Kanako Kondo, Ayuri Nagura, Mirai Yamazaki, Yoshitaka Ando, Eiji Munetsuna, Koji A. O. Suzuki, Koji Ohashi et al. · 2016 · Annals of Clinical Biochemistry International Journal of Laboratory Medicine
6. High levels of oxidized fatty acids in HDL impair the antioxidant function of HDL in patients with diabetes
   Juan Feng, Yunfeng Wang, Weixi Li, Yue Zhao, Yi Liu, Xingang Yao, Shuwen Liu, Ping Yu, Rongsong Li · 2022 · Frontiers in Endocrinology
7. Nicotinic acid: clinical considerations
   Anastazia A. Kei, Moses Elisaf · 2012 · Expert Opinion on Drug Safety
8. Beyond Statins: Emerging Evidence for HDL-Increasing Therapies and Diet in Treating Cardiovascular Disease
   Sterling Farrer · 2018 · Advances in Preventive Medicine
9. Effect of niacin monotherapy on high density lipoprotein composition and function
   Scott M. Gordon, Marcelo J. Amar, Kianoush Jeiran, Michael S. Stagliano, Emma Staller, Martin Peter Playford, Nehal N. Mehta, Tomáš Vaisar, Alan Thomas Remaley · 2020 · Lipids in Health and Disease
10. The difficult search for a ‘partner’ of statins in lipid-targeted prevention of vascular events: the re-emergence and fall of niacin
    Ulf Landmesser · 2013 · European Heart Journal
11. MicroRNA transport in cardiovascular complication of diabetes
    Andrea Caporali, Vladislav Miscianinov, Jaimy Saif, Costanza Emanueli · 2016 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
12. Hypertriglyceridemia and Atherosclerotic Carotid Artery Stenosis
    Yoichi Miura, Hidenori Suzuki · 2022 · International Journal of Molecular Sciences
13. Impact of Exercise on High-Density Lipoprotein Cholesterol in Adults with Overweight and Obesity: A Narrative Review
    Sameer Badri Al-Mhanna, César Leão, Wan Syaheedah Wan Ghazali, Mahaneem Mohamed, Alexios Batrakoulis, Hafeez Abiola Afolabi, Bishir Daku Abubakar, Monira I. Aldhahi, Mehmet Gülü, Fatma Hilal Yağın et al. · 2024 · Annals of Applied Sport Science
14. HDL in diabetic nephropathy has less effect in endothelial repairing than diabetes without complications
    Yufeng Li, Mingming Zhao, Dan He, Xuyang Zhao, Wenjing Zhang, Lixin Wei, Edgar Shaohua Huang, Liang Ji, Meng Zhang, Belinda B. Willard et al. · 2016 · Lipids in Health and Disease
15. Depletion in LpA-I:A-II particles enhances HDL-mediated endothelial protection in familial LCAT deficiency
    Monica Gomaraschi, Alice Ossoli, Samuela Castelnuovo, Sara Simonelli, Chiara Pavanello, G. Balzarotti, Marcello Arca, Alessia Di Costanzo, Tiziana Sampietro, Gaetano Vaudo et al. · 2017 · Journal of Lipid Research
16. A Current Update on the Role of HDL-Based Nanomedicine in Targeting Macrophages in Cardiovascular Disease
    Alankrita Rani, Gunther Marsche · 2023 · Pharmaceutics
17. High density lipoprotein from coronary artery disease patients caused abnormal expression of long non-coding RNAs in vascular endothelial cells
    Xiang Liu, Tiantian Wang, Yan Li, Mao‐Mao Shi, Hua-Ming Li, Hao‐Xiang Yuan, Zhi-Wei Mo, Jing Chen, Bin Zhang, Yangxin Chen et al. · 2017 · Biochemical and Biophysical Research Communications
18. Gender-specific association of metabolic syndrome and its components with arterial stiffness in the general Chinese population
    Mengjia Yue, Hongjian Liu, Minfu He, Fangyuan Wu, Xuanxuan Li, Yingxin Pang, Xiaodi Yang, Ge Zhou, Juan Ma, Meitian Liu et al. · 2017 · PLoS ONE
19. Cholesterol efflux capacity of large, small and total HDL particles is unaltered by atorvastatin in patients with type 2 diabetes
    Linda Liliana Muñóz-Hernández, Raúl Julián Ortiz-Bautista, Griselda X. Brito-Córdova, Francisco Lozano-Arvizu, Sharim Saucedo, Oscar A Pérez-Méndez, Alejandro Zentella‐Dehesa, Carolane Dauteuille, Marie Lhomme, Philippe Lesnik et al. · 2018 · Atherosclerosis
20. Associations of lipoprotein subclasses with risk of all‐cause and cardiovascular disease mortality in individuals with type 2 diabetes: A prospective cohort study
    Rui Li, Junxiang Chen, Qi Lu, Tingting Geng, Peng‐Fei Xia, Yi Wang, Liangkai Chen, Zhilei Shan, An Pan, Gang Liu · 2023 · Diabetes Obesity and Metabolism
21. Glymphatic function and its influencing factors in different glucose metabolism states
    Bin Tian, Chen Zhao, Jia-Li Liang, Huiting Zhang, Yifan Xu, Hui-Lei Zheng, Jia Zhou, Jiang-Nian Gong, Shuting Lu, Zisan Zeng · 2024 · World Journal of Diabetes
22. Extended-release niacin/laropiprant improves endothelial function in patients after myocardial infarction
    Urška Bregar, Borut Jug, Irena Keber, Matija Cevc, Miran Šebeštjen · 2013 · Heart and Vessels
23. Mutual Influences between Nitric Oxide and Paraoxonase 1
    Marta Marín, Carlos Moya, Salvador Máñez · 2019 · Antioxidants
24. Temporal Dynamics of High-Density Lipoprotein Proteome in Diet-Controlled Subjects with Type 2 Diabetes
    Karim G. Kheniser, Abdullah Ösme, CK Kim, Serguei Ilchenko, Takhar Kasumov, Sangeeta R. Kashyap · 2020 · Biomolecules
25. Diabetes induces gender gap on LCAT levels and activity
    Manouchehr Nakhjavani, Afsaneh Morteza, Reza J. Karimi, Zahra Banihashmi, Alireza Esteghamati · 2012 · Life Sciences
26. Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping
    Bradley Field Bale, Amy Lynn Doneen, David John Vigerust · 2018 · Frontiers in Cardiovascular Medicine
27. High Density Lipoprotein – Should we Raise it?
    Ulf Landmesser · 2012 · Current Vascular Pharmacology
28. New evidence for nicotinic acid treatment to reduce atherosclerosis
    Fabrizio Montecucco, Alessandra Quercioli, Franco Dallegri, Giorgio Luciano Viviani, François Mach · 2010 · Expert Review of Cardiovascular Therapy
29. Guía de práctica clínica de la ESC sobre diabetes, prediabetes y enfermedad cardiovascular, en colaboración con la European Association for the Study of Diabetes
    Lars Rydén, Grupo de Trabajo de la Sociedad Europea de Cardiología sobre diagnóstico y tratamiento de la cardiopatía isquémica estable, Peter J. Grant, Stefan D. Anker, Christian Berne, Francesco Cosentino, Nicolas Danchin, Christi Deaton, Javier Escaned, Hans Peter Hammes et al. · 2014 · Revista Española de Cardiología
30. Treatment with the herbal medicine, naoxintong improves the protective effect of high-density lipoproteins on endothelial function in patients with type 2 diabetes
    Pu Lv, Xunliang Tong, Qing Peng, Yuanyuan Liu, Haiqiang Jin, Ran Liu, Wei Sun, Bing Pan, Lemin Zheng, Yining Huang · 2016 · Molecular Medicine Reports
31. Adenosine deaminase, dipeptidyl peptidase-IV activities and lipid peroxidation are increased in the saliva of obese young adult
    Eduardo Ottobelli Chielle, Gabriela Bonfanti, Karine Santos De Bona, Rafael Noal Moresco, Maria Beatriz Moretto · 2015 · Clinical Chemistry and Laboratory Medicine (CCLM)
32. Elevated high density lipoprotein cholesterol and low grade systemic inflammation is associated with increased gut permeability in normoglycemic men
    M. Denise Robertson, Camilla Pedersen, Paul J. Hinton, Agampodi Mendis, Patrice D. Cani, Bruce Arthur Griffin · 2018 · Nutrition Metabolism and Cardiovascular Diseases
33. Dysfunctional high density lipoprotein failed to rescue the function of oxidized low density lipoprotein-treated endothelial progenitor cells: a novel index for the prediction of HDL functionality
    Chun‐Ming Shih, Feng‐Yen Lin, Jong‐Shiuan Yeh, Yi‐Wen Lin, Shih‐Hurng Loh, Nai-Wen Tsao, Hironori Nakagami, Ryuichi Morishita, Tatsuya Sawamura, Chi‐Yuan Li et al. · 2018 · Translational research
34. Vasoprotective Functions of High-Density Lipoproteins Relevant to Alzheimer’s Disease Are Partially Conserved in Apolipoprotein B-Depleted Plasma
    Emily B. Button, Megan Gilmour, Harleen K. Cheema, Emma M. Martin, Andrew M. Agbay, Jérôme Robert, Cheryl Lea Wellington · 2019 · International Journal of Molecular Sciences
35. HDL and Endothelial Function
    Yufei Wu, Yangkai Xu, Jie Chen, Mingming Zhao, Kerry‐Anne Rye · 2022 · Advances in experimental medicine and biology
36. High-density lipoprotein (HDL) cholesterol – more complicated than we think?
    Katarzyna Nessler, Adam Windak, Rafał Grzybczak, Michał B. Nessler, Aleksander Siniarski, Grzegorz Gajos · 2018 · Annals of Agricultural and Environmental Medicine
37. Scavenger Receptor Class B, Type I: A Promising Immunotherapy Target
    Jessica Fioravanti, José Medina‐Echeverz, Pedro Berraondo · 2011 · Immunotherapy
38. Citrulline increases cholesterol efflux from macrophages in vitro and ex vivo via ATP-binding cassette transporters
    Harumi Uto‐Kondo, Makoto Ayaori, Kazuhiro Nakaya, Shunichi Takiguchi, Emi Yakushiji, Masatsune Ogura, Yoshio Terao, Hideki Ozasa, Makoto Sasaki, Tomohiro Komatsu et al. · 2014 · Journal of Clinical Biochemistry and Nutrition
39. Advances in the Study of the Antiatherogenic Function and Novel Therapies for HDL
    Peiqiu Cao, Haitao Pan, Tiancun Xiao, Ting Zhou, Jiao Guo, Zhengquan Su · 2015 · International Journal of Molecular Sciences
40. Lipoproteins and Cardiovascular Redox Signaling: Role in Atherosclerosis and Coronary Disease
    Arash Haghikia, Ulf Landmesser · 2017 · Antioxidants and Redox Signaling
41. Sex Difference Impacts on the Relationship between Paraoxonase-1 (PON1) and Type 2 Diabetes
    Valentina Rosta, Alessandro Trentini, Angelina Passaro, Giovanni Zuliani, Juana María Sanz, Cristina Bosi, Gloria Bonaccorsi, Tiziana Bellini, Carlo Cervellati · 2020 · Antioxidants
42. Importance of high-density lipoprotein quality
    Valentina Kon, Talat Alp Ikizler, Sergio Fazio · 2013 · Current Opinion in Nephrology & Hypertension
43. Weight and inflammation are the major determinants of vascular dysfunction in the aortae of db/db mice
    Nada A. Sallam, Anat Fisher, Saeid Golbidi, Ismail Laher · 2011 · Naunyn-Schmiedeberg s Archives of Pharmacology
44. Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome
    Cathérine Gebhard, Éric Rhéaume, Colin Berry, Geneviève Brand, Anne‐Elen Kernaleguen, Gabriel Théberge-Julien, Mohammad Afaque Alam, Candace Y.W. Lee, Laurianne Boileau, Malorie Chabot-Blanchet et al. · 2017 · PLoS ONE
45. Paraoxonase responses to exercise and niacin therapy in men with metabolic syndrome
    K J Taylor, Eric P. Plaisance, A. Jack Mahurin, Michael L. Mestek, José Moncada‐Jiménez, Peter W. Grandjean · 2014 · Redox Report
46. Fenofibrate and extended-release niacin improve the endothelial protective effects of HDL in patients with metabolic syndrome
    Monica Gomaraschi, Alice Ossoli, Maria Pia Adorni, Elisabetta Damonte, Eric J. Niesor, Fabrizio Veglia, Guido Franceschini, Renée Benghozi, Laura Calabresi · 2015 · Vascular Pharmacology
47. Dyslipidemia and atherosclerotic carotid artery stenosis
    Yoichi Miura, Hidenori Suzuki · 2019 · Vessel Plus
48. Dysfunctional high-density lipoproteins in diabetes mellitus
    O. N. Poteryaeva, Усынин Иван Федорович · 2022 · Problems of Endocrinology
49. High-Density Lipoprotein: Structural and Functional Changes Under Uremic Conditions and the Therapeutic Consequences
    Mirjam Schuchardt, Markus Tölle, Markus van der Giet · 2014 · Handbook of experimental pharmacology
50. Humoral Immunity Against HDL Particle: A New Perspective in Cardiovascular Diseases?
    Nathalie Satta, Miguel A. Frias, Nicolas Vuilleumier, Sabrina Pagano · 2019 · Current Pharmaceutical Design
51. Correlation between serum free fatty acids levels and Gensini score in elderly patients with coronary heart disease.
    Liyun He, Junfeng Zhao, Jiangli Han, Shanshan Shen, Xu‐Jiao Chen · 2014 · Europe PMC (PubMed Central)
52. HDL metabolism and function in diabetes mellitus
    Blake J. Cochran, Thomas W King, Kévin Chemello, Shane Ross Thomas, Kerry‐Anne Rye · 2025 · Nature Reviews Endocrinology
53. Correlation between endothelial function measured by finger plethysmography in children and HDL-mediated eNOS activation — a preliminary study
    Ulrike Müller, Yae Matsuo, Maximilian Lauber, Claudia Walther, Andreas Oberbach, Gerhard C Schuler, Volker Adams · 2013 · Metabolism
54. Low density lipoprotein cholesterol level inversely correlated with coronary flow velocity reserve in patients with Type 2 diabetes.
    Jie Yu, Jiangli Han, Liyun He, Xin-Heng Feng, Weihong Li, Jieming Mao, Wei Gao, Guang Wang · 2013 · Europe PMC (PubMed Central)
55. Impaired High-Density Lipoprotein Anti-Oxidant Function Predicts Poor Outcome in Critically Ill Patients
    Lore Schrutka, Georg Goliasch, Brigitte Meyer, Raphael Wurm, Lorenz Koller, Lukas Kriechbaumer, Gottfried Heinz, Richard Pacher, Irene Marthe Lang, Klaus Distelmaier et al. · 2016 · PLoS ONE
56. Gender-related impact on outcomes of high density lipoprotein in acute ST-elevation myocardial infarction
    Klaus Distelmaier, Lore Schrutka, Raphael Wurm, Veronika Seidl, Henrike Arfsten, A. Cho, Shankarappa Manjunatha, Thomas Perkmann, Guido Strunk, Irene Marthe Lang et al. · 2016 · Atherosclerosis
57. Lipid profile in type 2 patients with diabetes from Tlemcen: A Western Algerian population
    Mohammed Nadjib Rahmoun, Chems Edinne Ghembaza, Amine Ghembaza · 2019 · Diabetes & Metabolic Syndrome Clinical Research & Reviews
58. Rationale and design of a multicenter, randomized, patients-blinded two-stage clinical trial on effects of endothelial function test in patients with non-obstructive coronary artery disease (ENDOFIND)
    Huan Liu, Gaoqiang Xie, Wei Huang, Jinbo Liu, Na Zhao, Michel Corban, Amir Lerman, Yangfeng Wu, Hongyu Wang · 2020 · International Journal of Cardiology
59. Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production
    Umberto Capece, Chiara Pavanello, Francesca Cinti, Lucia Leccisotti, Teresa Mezza, Gea Ciccarelli, Simona Moffa, Gianfranco Di Giuseppe, Laura Soldovieri, Michela Brunetti et al. · 2023 · Diabetes Therapy
60. Klinische Bedeutung des HDL-Cholesterins
    Winfried März, Marcus Edi Kleber, Hubert Scharnagl, Thimoteus Speer, Stephen Zewinger, Andreas Ritsch, Klaus Georg Parhofer, Arnold von Eckardstein, Ulf Landmesser, Ulrich Laufs · 2016 · Herz
61. N2L, a novel lipoic acid-niacin dimer protects HT22 cells against β-amyloid peptide-induced damage through attenuating apoptosis
    Rikang Wang, Lang Zhang, Rifang Liao, Qian Li, Rongbiao Pi, Xiaobo Yang · 2019 · Metabolic Brain Disease
62. The role of myeloperoxidase as a biomarker in atherosclerotic cardiovascular disease
    Hamideh Amirfakhryan, Karl James New · 2024 · Cardiology Plus
63. Effective high-density lipoprotein cholesterol is associated with carotid intima-media thickness and vascular events after acute ischemic stroke
    Edzard Schwedhelm, Steffen Tiedt, Susanne Lezius, Teresa A. Wölfer, Märit Jensen, Robert Schulz, Rainer H. Böger, Christian P Gerloff, Götz Thomalla, Chi‐un Choe · 2022 · Atherosclerosis
64. The beneficial effects of HDL-C on atherosclerosis: rationale and clinical results
    Carlos G. Santos‐Gallego, Francisco Torres, Juan J. Badimón · 2011 · Clinical Lipidology
65. Effect of Rosuvastatin on Cholesterol Efflux Capacity and Endothelial Function in Type 2 Diabetes Mellitus and Dyslipidemia
    Kyong Yeun Jung, Kyoung Min Kim, Sun Kyoung Han, Han Mi Yun, Tae Jung Oh, Sung Hee Choi, Kyong Soo Park, Hak Chul Jang, Soo Kyung Lim · 2017 · Circulation Journal · Retracted
66. Hyperactivity and Pro-inflammatory Functions of Platelets in Diabetes
    Jordan Greaves, Giordano Pula · 2025 · Frontiers in Bioscience-Landmark
67. High-density lipoproteins. Part 2. Impact of disease states on functionality
    Anna Gluba-Brzózka, Robert Olszewski, Beata Franczyk, Ewelina Młynarska, Magdalena Rysz-Górzyńska, Jacek Rysz, Stanisław Surma, Sohum Sheth, Maciej Banach, Peter Paul Toth · 2025 · American Journal of Preventive Cardiology
68. Ezetimibe/statin combination therapy to treat patients with type 2 diabetes
    Michel Farnier · 2015 · Atherosclerosis Supplements
69. The Year in Atherothrombosis
    Javier Sanz, Valentı́n Fuster · 2011 · Journal of the American College of Cardiology
70. Reproducibility and biological variability of HDL's vascular functional assays
    Francis O'Neill, Eve McLoughlin, Meliana Riwanto, Jasmin Manz, Andreas Adler, Emma Sutill, Tauseef Ahmad Khan, Rachel Haywood, Christopher W. M. Kay, Francesco D’Aiuto et al. · 2015 · Atherosclerosis
71. Environmental and Varietal Effects on Niacin Content of Raw and Roasted Peanuts
    Madison Lisbeth Whitley, Thomas George Isleib, Keith William Hendrix, Timothy H. Sanders, Lisa L. Dean · 2011 · Peanut Science
72. Marked Changes in Serum Amyloid A Distribution and High‐Density Lipoprotein Structure during Acute Inflammation
    Shitsuko Shimano, Ryunosuke Ohkawa, Mayu Nambu, Mai Sasaoka, Azusa Yamazaki, Yuki Fujii, Yuna Horiuchi, Shao-Jui Lai, Takahiro Kameda, Naoya Ichimura et al. · 2021 · BioMed Research International
73. Insulin Resistance, Type 2 Diabetes and Atherosclerosis
    Leonardo Roever · 2014 · Journal of Diabetes & Metabolism
74. Relationship between cardio-ankle vascular index and homocysteine in hypertension subjects with hyperhomocysteinemia
    Jinbo Liu, Huan Liu, Hongwei Zhao, Yingyan Zhou, Lihong Li, Hongyu Wang · 2016 · Clinical and Experimental Hypertension
75. The impact of myeloperoxidase on HDL function in myocardial infarction
    Uwe J.F. Tietge · 2018 · Current Opinion in Endocrinology Diabetes and Obesity
76. High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels
    Beata Franczyk, Ewelina Młynarska, Magdalena Rysz-Górzyńska, Anna Gluba-Brzózka, Jacek Rysz, Sohum Sheth, Stanisław Surma, Maciej Banach, Peter Paul Toth · 2025 · American Journal of Preventive Cardiology
77. Influence of high density lipoprotein cholesterol levels on circulating monocytic angiogenic cells functions in individuals with type 2 diabetes mellitus
    Daniela Lucchesi, Simona Georgiana Popa, Verónica Sancho, Laura Giusti, Monia Garofolo, Giuseppe Daniele, Laura Pucci, Roberto Miccoli, Giuseppe Penno, Stefano Del Prato · 2018 · Cardiovascular Diabetology
78. Correlation of serum HDL level with HRV indices using multiple linear regression analysis in patients with type 2 diabetes mellitus
    Fareedabanu A. Balikai, S. B. Javali, Varsha M. Shindhe, Neeta Deshpande, Jyoti M. Benni, Darshit P. Shetty, Nitin Kapoor, Kamaruddin Jaalam · 2022 · Diabetes Research and Clinical Practice
79. Wytyczne ESC dotyczące cukrzycy, stanu przedcukrzycowego i chorób układu sercowo- -naczyniowego opracowane we współpracy z EASD
    ESC EASD · 2013 · Kardiologia Polska
80. Tachometer for Reverse Cholesterol Transport?
    Arnold von Eckardstein · 2012 · Journal of the American Heart Association
81. A new look at HDL in coronary disease: can we escape natural history?
    Stephan Gielen, Ulf Landmesser · 2011 · Heart
82. Association between high-density lipoprotein cholesterol to apolipoprotein A ratio and diabetic retinopathy: A cross-sectional study
    Cong Zhang, Wenjian Lin, Qian Xu, Hongxue Li, Chengye Xu, Xuefei Ma, Ming Hao, Hongyu Kuang · 2023 · Journal of Diabetes and its Complications
83. No Improvement of High-Density Lipoprotein (HDL) Vasorelaxant Effect Despite Increase in HDL Cholesterol Concentration in Type 2 Diabetic Patients Treated With Glitazones
    Laurence Perségol, Laurence Duvillard, Serge Monier, Marie‐Claude Brindisi, Benjamin Bouillet, Jean‐Michel Petit, Bruno L Vergès · 2014 · The Journal of Clinical Endocrinology & Metabolism
84. Physiopathologie de la dyslipidémie du diabète de type 2 : nouvelles perspectives
    Bruno L Vergès · 2019 · Médecine des Maladies Métaboliques
85. Genetic variation in DPP-IV gene linked to predisposition of T2DM: A case control study
    Archna Bhargave, Kiran Devi, Imteyaz Ahmad, Anita Yadav, Ranjan Gupta · 2022 · Journal of Diabetes & Metabolic Disorders
86. Acute myocardial infarction preferentially alters low-abundant, long-chain unsaturated phospholipid and sphingolipid species in plasma high-density lipoprotein subpopulations
    Maharajah Ponnaiah, Emile Zakiev, Marie Lhomme, Fabiana Hanna Rached, Laurent Camont, Carlos Vicente Serrano Junior, Raul Dias Santos, M. John Chapman, Alexander Nikolaevich Orekhov, Anatol Kontush · 2023 · Atherosclerosis Plus
87. The clinical relevance of dysfunctional HDL in patients with coronary artery disease: A 3-year follow-up study
    Francesco Paneni, Francesco Cosentino, Federica Marrara, Francesca Palano, Giuliana Capretti, Mario Gregori, Giuliano Tocci, Marco Testa, Massimo Volpe · 2012 · International Journal of Cardiology
88. Levels of Myeloperoxidase, Malondialdehyde and Lipid Profile in Type 2 Diabetic Patients on Metformin Versus Glibenclamide Therapy
    Zainab Haitham Fathi, Jehan Abdulwahab Mohammad, Marwah H. Mohammed · 2020 · Systematic Reviews in Pharmacy
89. Differences in HDL-related coronary heart disease risk between individuals with and without diabetes
    Jun‐Xiang Chen, Qi Lu, Tingting Geng, Yuexuan Wang, Yi Wang, Rui Li, Peng‐Fei Xia, Kunquan Guo, Kun Yang, Wen-Wei Tong et al. · 2024 · Atherosclerosis
90. Risk for Behçet’s disease gauged via high-density lipoprotein cholesterol: a nationwide population-based study in Korea
    Yeong Ho Kim, Hyun Jee Kim, Jin Woo Park, Kyungdo Han, Yong Gyu Park, Young Bok Lee, Ji Hyun Lee · 2022 · Scientific Reports
91. Carbamylated lipoproteins in diabetes
    Damien Denimal · 2023 · World Journal of Diabetes
92. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
    Mohamed H. Ahmed · 2010 · Journal of Cardiovascular Medicine
93. Clinical Trials of HDL Cholesterol–Raising Therapy: What Have We Learned About the HDL Hypothesis from AIM-HIGH?
    Robert S. Rosenson · 2012 · Current Atherosclerosis Reports
94. Apolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties
    Zui Liu, Yang Cao, Xiaolong Liao, Zhi‐Jun Ou, Zhi-Wei Mo, Yi-Fang Liu, Ya-Ting Chen, Ze-Long Liu, Jianjun Gao, Da-Sheng Ning et al. · 2024 · Journal of Cardiovascular Translational Research
95. Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized Study
    Anastazia A. Kei, Moses Elisaf, Elisavet Moutzouri, Stavroula Tsiara, Evangelos N. Liberopoulos · 2011 · International Journal of Hypertension
96. HDL-C/apoA-I Ratio Is Associated with the Severity of Coronary Artery Stenosis in Diabetic Patients with Acute Coronary Syndrome
    Lizhe Sun, Manyun Guo, Chenbo Xu, Xiangrui Qiao, Yiming Hua, Gulinigaer Tuerhongjiang, Bowen Lou, Ruifeng Li, Xiaofang Bai, Juan Zhou et al. · 2021 · Disease Markers
97. HDL and Endothelium
    Raul Cavalcante Maranhão, Antonio C. Monteiro Filho, Gilbert Alexandre Sigal, Antônio Carlos Palandri Chagas, Protásio Lemos da Luz · 2018 · Elsevier eBooks
98. Pleiotropic Functions of HDL Lead to Protection from Atherosclerosis and Other Diseases
    Vassilis I. Zannis, Andreas K. Kateifides, Panagiotis Fotakis, Eleni E. Zanni, Dimitris Kardassis · 2012 · InTech eBooks
99. Effects of Diabetic HDL on Endothelial Cell Function
    Dan He, Bing Pan, Hui Ren, Lemin Zheng · 2014 · Cardiovascular & Haematological Disorders - Drug Targets
100. HDL functionality in diabetes mellitus: potential importance of glycation
     Nahla Nabil Younis, Paul N. Durrington · 2012 · Clinical Lipidology